Home/Pipeline/FLQ-106

FLQ-106

Pterygium

PreclinicalDiscovery/Research

Key Facts

Indication

Pterygium

Phase

Preclinical

Status

Discovery/Research

Company

About Feliqs

Clinical-stage ophthalmology company developing innovative therapies for retinopathy of prematurity and age-related macular degeneration.

View full company profile

Therapeutic Areas

Oncology Immunology